Chính phủ Đức đầu tư 300 triệu euro nghiên cứu vắcxin chống COVID-19

Bộ Kinh tế Đức ngày 15/6 cho biết chính phủ nước này sẽ đầu tư 300 triệu euro vào công ty dược phẩm sinh học CureVac để cùng nghiên cứu tìm kiếm vắcxin chống virus SARS-CoV-2 gây bệnh viêm đường hô hấp cấp COVID-19 dựa trên công nghệ RNA thông tin (mRNA), giúp cơ thể kích hoạt cơ chế tự sản xuất "vũ khí" để nhận biết và tiêu diệt virus.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Hy vọng mới trong điều trị ung thư tuyến tụy

Hy vọng mới trong điều trị ung thư tuyến tụy

Thế giới
(Baothanhhoa.vn) - Một loại thuốc thử nghiệm có tên Daraxonrasib đang mở ra hy vọng mới trong điều trị ung thư tuyến tụy, sau khi kết quả nghiên cứu công bố trên tạp chí y khoa New England Journal of Medicine cho thấy thuốc có thể giúp kéo dài gấp đôi thời gian sống...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh